Veracyte
An Associate Director, Bioinformatics Development at Veracyte leads bioinformatics strategy and development for next-generation minimal residual disease (MRD) laboratory-developed tests (LDTs). The role involves technical leadership, cross-program coordination, and mentorship of computational development scientists.
Headquarters
South San Francisco, California, United States
Company Size
501-1000 employees
Founded
2008
Veracyte is a genomic diagnostics company that develops and delivers molecular tests to provide clinicians with actionable molecular insights for cancer care. Their high‑performing tests support patient management across thyroid, prostate, bladder, breast, and lung cancers, helping physicians give patients informed answers now and tailor personalized treatment plans. Veracyte focuses on translating genomic data into clinically useful results to improve diagnostic accuracy and guide therapy decisions. Their mission—"Exceptional cancer care begins with exceptional diagnostics"—reflects a commitment to advancing precision oncology and better patient outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Veracyte.
36% above the average for this role
Veracyte to Participate in Upcoming Investor Conferences
3 weeks ago
Sr. Bioinformatics Scientist, MRD
Abbott Laboratories
Bioinformatics Analysts/Engineers
Parsons
Sr. Bioinformatics Scientist, MRD
Abbott Laboratories
Senior Bioinformatics Analyst/Engineer
Parsons
Part Time Lecturer, Applied Bioinformatics (Cell & Gene Therapies Program)
Northeastern University
Director, Bioinformatics
Illumina